3.8 Article

Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21

Marco Falcone et al.

Summary: From November 2020 to March 2021, hvKp was isolated in 36 COVID-19 patients, with 80.6% developing infections including bloodstream infections, ventilator-associated pneumonias, and complicated urinary tract infections. The majority of infections were caused by ST147 strains carrying multiple resistance genes. The 30-day mortality rate among infected patients was 48.3%.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

Article Infectious Diseases

Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)

Marco Falcone et al.

Summary: The study found that NDM-Kp is associated with a higher risk of BSI compared to KPC-Kp, and this association seems to be strongly related to the high-risk clone ST147.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Infectious Diseases

Carbapenemase-producing Enterobacterales infections in COVID-19 patients

Vicente Pintado et al.

Summary: Patients with COVID-19 have an increased risk of CPE infections, which often present as severe, nosocomial infections in critically-ill patients and are associated with a higher mortality rate.

INFECTIOUS DISEASES (2022)

Article Immunology

Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients

Marco Falcone et al.

Summary: In this study, cefiderocol was used to treat patients with bacteremia or ventilator-associated pneumonia caused by drug-resistant strains, showing a 70% clinical success rate and 90% survival rate. However, two patients experienced microbiological failure, highlighting the need for future prospective studies to further evaluate the effectiveness of the treatment.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

Cristina Mussini et al.

Summary: This study summarized the literature on the management of COVID-19 to assist frontline healthcare workers in better understanding the current evidence for disease treatment and guidelines. The research team conducted a detailed review of literature and clinical trial results to develop treatment indications for different COVID-19 patients.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Tommaso Bardi et al.

Summary: Co-infection of bacteria and fungi is common in ICU-admitted COVID-19 patients and usually presents as a severe form of infection, associated with a high mortality rate and longer ICU stay.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

Marco Falcone et al.

Summary: Superinfections with bacteria and fungi are common in hospitalized patients with COVID-19, especially in those receiving empirical broad-spectrum antibiotics and immunomodulatory drugs. Infection control measures need to be reinforced to prevent and manage superinfections effectively.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Infectious Diseases

Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital

Angela Gomez-Simmonds et al.

Summary: The study found an increased prevalence of CPE infections among COVID-19 patients, mainly caused by Klebsiella pneumoniae and Enterobacter cloacae. These pathogens are predominantly multidrug-resistant, leading to frequent treatment failures. Nanopore sequencing revealed distinct ST258 lineages, suggesting a potential resurgence of CPE post the global pandemic.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Medicine, General & Internal

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study

Daniele Roberto Giacobbe et al.

Summary: This study aimed to assess the incidence rate of ventilator-associated pneumonia in COVID-19 patients in intensive care units, finding that VAP is frequent and associated with a high fatality rate, likely due to the cumulative impact of the underlying viral disease and superimposed bacterial infections.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Immunology

Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies

Cornelius J. Clancy et al.

Summary: Research shows that potential bacterial lung superinfections were present in 32% of patients who died with COVID-19, with most of them receiving antimicrobial treatment. The most common pathogens identified in postmortem studies included Acinetobacter baumannii, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Superinfections were rarely the direct cause of death, ranking third behind other factors.

OPEN FORUM INFECTIOUS DISEASES (2021)

Editorial Material Microbiology

Tackling Antimicrobial Resistance in the Shadow of COVID-19

Ami Patel

Summary: The COVID-19 pandemic has posed a challenge to combating antimicrobial-resistant bacterial infections, with an increased use of antimicrobial agents and antibiotics. Sexually transmitted infections, often caused by drug-resistant pathogens, have been underreported during the pandemic, highlighting the importance of research in this area. In a recent article, researchers focused on protection against Neisseria gonorrhoeae infection through the delivery of an antibody modified for increased complement activation, highlighting the potential of nucleic acid approaches in combating antimicrobial resistance.
Article Infectious Diseases

Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

Marco Falcone et al.

Summary: This study aimed to evaluate the risk of hospitalization or death in patients infected by SARS-CoV2 variants of concern receiving combinations of monoclonal antibodies. The results showed that in patients infected by the SARS-CoV-2 Gamma variant, the use of bamlanivimab/etesevimab should be used with caution due to the high risk of disease progression.

INFECTIOUS DISEASES AND THERAPY (2021)

Letter Immunology

Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units

Ashka Patel et al.

Summary: The rapid spread of multidrug-resistant gram-negative bacteria among patients in a dedicated coronavirus disease care unit in a Maryland hospital was attributed to factors such as critical illness, high antibiotic use, double occupancy of single rooms, and modified infection prevention practices. Surveillance culturing played a key role in identifying and controlling the outbreak.

EMERGING INFECTIOUS DISEASES (2021)

Article Cell Biology

Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients

Philipp K. Buehler et al.

Summary: Superinfections are common among COVID-19 patients with acute respiratory distress syndrome, leading to lower survival rates, longer intensive care treatment, and reduced ventilator-free days despite the use of empirical antibiotic therapy.

CELL REPORTS MEDICINE (2021)

Article Critical Care Medicine

Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region

Gauthier Blonz et al.

Summary: The study analyzed data from 188 patients hospitalized for severe COVID-19 in ICUs, showing a high incidence of VAP with a significant proportion of enterobacteria, and higher risk in male patients. Complications such as abscess and empyema were not exceptional in VAP cases.

CRITICAL CARE (2021)

Article Immunology

The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections

Heather Henderson et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)